$94.97
0.00 (0%)
Genentech, Inc. (DNA.DL)
CAPS Rating:
The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.
No one has written a Pitch for DNA.DL stock yet. Tell us why you think DNA.DL will outperform or underperform the S&P 500.

RSS Headlines
Fool UK